Omeros Corp. (NASDAQ:OMER) stock fell sharply Tuesday after the biotechnology company reported mixed third-quarter 2026 results, with adjusted earnings exceeding Wall Street expectations but revenue falling short. The company reported adjusted earnings of 6 cents per share, beating the consensus estimate of 3 cents. Revenue reached $35.93 million, missing the consensus estimate of $37.27 million. Third-Quarter Financial Results Omeros reported...
Why Is Omeros Stock Trading Lower Tuesday?
Omeros Corp. (NASDAQ:OMER) stock fell sharply Tuesday after the biotechnology company reported mixed third-quarter 2026 ...
By Dhallo News · November 17, 2026 at 11:35 PM IST
Have feedback on this article?Report error or suggestion
